Our Portfolio

Healthcare


Anexigen

Anexigen

Anexigen developes novel methods and compositions designed to combat existing and burgeoning antimicrobial threats. Co-investors include Avalon Ventures.

Ankasa Regenerative Therapeutics
Annexon Biosciences

Annexon Biosciences

Annexon Biosciences is developing therapeutic products that halt the progression of complement-mediated neurodegeneration. Co-investors include Clarus Ventures, New Enterprise Associates, Novartis, and Stanford University.

Arista MD

Arista MD

Arista MD offers a customized referral management system to meet the needs of primary and specialty care physicians while significantly reducing costs in “inappropriate” referrals. Co-investors include Avalon Ventures.

CareWell Urgent Care

CareWell Urgent Care

CareWell Urgent Care is establishing and operating urgent care centers in the New England area. Co-investors include CHL Medical Partners.

Cellular Approaches

Cellular Approaches

Cellular Approaches operates a biotechnology company designed to create augmented innate immunity to treat life-threatening diseases. Co-investors include Avalon Ventures.

Future Family

Future Family

Future Family provides reproductive healthcare services intended to offer women and couples comprehensive fertility testing and support. Co-investors include Montage Ventures.

Galera Therapeutics

Galera Therapeutics

Galera Therapeutics is developing biopharmaceuticals targeting oxygen metabolic pathways to treat mucositis, fibrosis, and cancer. Co-investors include New Enterprise Associates, and Novartis Venture Fund. In November 2019 Galera Therapeutics went public (NASDAQ: GRTX).

Gynesonics

Gynesonics

Gynesonics is a women’s healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids. Co-investors include Abingworth, HBM Partners, and InterWest.

Intervene

Intervene

Intervene is a catheter-based technology to create native vein valves in the lower leg to treat severe systems associated with deep vein valve failure. Co-investors include Launch Capital and Rivervest Partners.

Karuna Labs

Karuna Labs

Karuna Labs provides a virtual reality based pain and physical therapy platform. Co-investors include Baseline Ventures.

Lemonaid Health

Lemonaid Health

Lemonaid Health is leading a second wave of telehealth where technology algorithms power quality care. Lemonaid leverages evidence-based guidelines and the most up-to-date clinical protocols to offer a service direct to consumer for less than typical co-pays. Lemonaid is focused on creating a revolutionized patient experience and improving and optimizing clinical care through the advancements in machine learning and AI. Co-Investors include Adaptive Healthcare Fund, 415 Ventures, Hikma Ventures, Novartis Venture Fund, and Vega Ventures.

Lexent Bio

Lexent Bio

Lexent Bio developes liquid biopsy technology designed to diagnose and treat cancer. Co-investors include Draper Fisher Jurvetson.

Mirna Therapeutics

Mirna Therapeutics

Mirna Therapeutics is developing replacement therapy for cancer treatment by harnessing the power of tumor suppressor miRNAs to kill cancer cells. Co-investors include New Enterprise Associates, Pfizer Venture Investments, Soffinova Ventures, and Osage University Partners. In October 2015, Mirna Therapeutics went public. (NASDAQ: MIRN)

ORIC Pharmaceuticals

ORIC Pharmaceuticals

ORIC Pharmaceuticals is a developer of novel therapies intended to overcome resistance in cancer. Co-investors include Arromark, Casdin and Invus.

PowerVision

PowerVision

Powervision has developed the FluidVision® intraocular lens implant, designed to restore the vision of those affected by presbyopia and/or cataracts. Co-investors include Aisling Capital, ATV, Frazier Healthcare Ventures, and Venrock. Aquired by Alcon in 2019.

RQx Pharmaceuticals

RQx Pharmaceuticals

RQx is discovering and developing novel broad-spectrum antibiotics. Co-investors include Avalon Ventures. Acquired by Genetech in 2013.

Scout Bio

Scout Bio

Gene therapy based pharmaceuticals for veterinary applications. Co-investors include Frazier Healthcare Ventures and Adage Capital.

Spirox

Spirox

Spirox is developing a minimally-invasive treatment for nasal valve collapse.Co-investors include Aperture Ventures, Western Technology Investments, and Venrock. Acquired by Entellus Medical (NASDAQ: ENTL)

SynthoRX

SynthoRX

SynthoRX is advancing the breakthrough technology of synthetic DNA bases that can be replicated in vivo for numerous medical and technological applications. Co-investors include Avalon Ventures. In December 2018, SynthroRX went public (NASDAQ: THOR)and was acquired by Sanofi in 2019.

Tatch

Tatch

Tatch is a state-of-the-art diagnostic and outcome management patch, that provides high-quality sleep analysis in maximal comfort. Co-investors include Spark Capital and Abstract Ventures.

The Well

The Well

The Well is a private members club based around the concept of 360-degree wellness. Co-investors include New Enterprise Associates.